Having developed an algorithm that discovered a large quantity of drug-producing bacteria in and on humans, Fischbach has turned his lab’s attention to studying their populations and interactions with each other. This, he posits, can greatly influence a person’s overall health and disease.
Department of Bioengineering and Therapeutic Sciences
Funding for Fischbach’s research is provided by the National Institutes of Health, Probiotics Research Council, Program for Breakthrough Biomedical Research and the W.M. Keck Foundation.